5,6-Dimethoxyisoindoline is an organic compound characterized by its isoindoline structure, which features a bicyclic framework consisting of a benzene ring fused to a five-membered nitrogen-containing ring. The presence of two methoxy groups (-OCH3) at the 5 and 6 positions of the isoindoline ring significantly influences its chemical properties, including its reactivity and solubility. This compound is typically a solid at room temperature and may exhibit a range of colors depending on its purity and crystalline form. It is of interest in various fields, including medicinal chemistry, due to its potential biological activities and applications in the synthesis of more complex molecules. The methoxy substituents can enhance the compound's lipophilicity, potentially affecting its pharmacokinetic properties. As with many organic compounds, 5,6-dimethoxyisoindoline should be handled with care, observing appropriate safety protocols to mitigate risks associated with chemical exposure. Its specific applications and reactivity can vary, making it a subject of ongoing research in organic synthesis and drug development.

5,6-DIMETHOXYISOINDOLINE

5,6-Dimethoxyisoindoline is a novel acetylcholine esterase inhibitor with high affinity for serotonin and dopamine receptors. It has been shown to have anti-cancer properties in vitro. 5,6-Dimethoxyisoindoline is rapidly taken up by cancer cells, which leads to cell cycle arrest in the G1 phase and death of cancer cells. This drug also binds to serotonin and dopamine receptors, which may be responsible for its anti-depressant effects. 5,6-Dimethoxyisoindoline has been shown to have low affinity for other receptors such as muscarinic acetylcholine receptors or α adrenergic receptors.

CAS 114041-16-6: 5,6-DIMETHOXYISOINDOLINE

5,6-Dimethoxyisoindoline

Ref: 3D-FD171291

5,6-Dimethoxyisoindoline

Ref: 54-OR89235

5,6-Dimethoxyisoindoline

Ref: 10-F605864

1H-Isoindole, 2,3-dihydro-5,6-dimethoxy-

Ref: IN-DA000AD8